Advancing medicine through rigorous science.
The International Medexia is a peer-reviewed, open-access journal publishing frontier research in medicine, biotechnology, and the life sciences — curated by a global editorial board.
Current issue
Frontiers in Precision Medicine
14
Articles
34d
Avg review
OA
Open access
2,480+
640
94
34 days
Featured articles from the current issue
Hand-selected by our editorial board — spanning genetics, neuroscience and global health.
A journal built for the next decade of medicine.
Founded in 2013, The International Medexia is a quarterly, open-access journal committed to transparent science. We publish high-impact original research, systematic reviews, and policy-shaping perspectives from researchers in 94 countries.
Rigorous peer review
Double-blind review by a global board of 640+ specialists across 28 clinical domains.
Open access, always
Every article published under CC-BY so findings reach clinicians, patients and policy makers.
Fast, transparent decisions
First decisions in under 34 days on average — with full reviewer transparency on request.
“Medexia is setting the standard for how transparent, open-access medical research should be published — fast reviews, rigorous science, and a commitment to equity.”
Prof. Elena Markov, MD, PhD
Editor-in-Chief · Karolinska Institute
Acceptance rate
23%
Frequency
Quarterly
ISSN
3022-0041
Publish research that moves medicine forward.
Join 2,000+ authors who have trusted Medexia with their work. First decisions in under 34 days. Open access. Worldwide indexing.
34 days
Avg. first decision
CC-BY
Open access license
5 indexes
Scopus, PMC, DOAJ…
94
Countries reached